Anti-tumoral effects of novel lymphatic delivery of anti-CTLA-4 in a metastatic murine breast cancer model

被引：0
|
作者：
Kwon, Sunkuk [1 ]
Velasquez, Fred Christian [1 ]
Ross, Russel F. [2 ]
Hwu, Wen-Jen [3 ]
Sevick-Muraca, Eva M. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[2] Kimberly Clark Inc, Roswell, GA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-LB-005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-005
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of psoralens as anti-tumoral agents in breast cancer cells
    Panno, Maria Luisa
    Giordano, Francesca
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (03): : 348 - 358
  • [2] Breast cancer cryoablation in combination with anti-CTLA-4 increases T cell activation in a murine tumor model
    de Miranda, Flavia Sardela
    Babcock, Rachel
    Castro, Maribel
    Khan, Sonia Y.
    Roach, Carsen
    Hintelmann, Thomas
    Furr, Kathryn
    Lee, Chang H.
    Boligala, Geetha P.
    Rasha, Fahmida
    Brandi, Luis
    Gill, Harvinder S.
    Pruitt, Kevin
    Rahman, Rakhshanda L.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [3] Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model
    Nathalie Esber
    Clément Cherbonnier
    Michèle Resche-Rigon
    Abdallah Hamze
    Mouad Alami
    Jérôme Fagart
    Hugues Loosfelt
    Marc Lombès
    Nathalie Chabbert-Buffet
    Hormones and Cancer, 2016, 7 : 137 - 147
  • [4] Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model
    Esber, Nathalie
    Cherbonnier, Clement
    Resche-Rigon, Michele
    Hamze, Abdallah
    Alami, Mouad
    Fagart, Jerome
    Loosfelt, Hugues
    Lombes, Marc
    Chabbert-Buffet, Nathalie
    HORMONES & CANCER, 2016, 7 (02): : 137 - 147
  • [5] Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
    Lipson, Evan J.
    Drake, Charles G.
    CLINICAL CANCER RESEARCH, 2011, 17 (22) : 6958 - 6962
  • [6] Tumor eradication in a murine model of glioma with vaccination and anti-CTLA-4 but not anti-PD-1
    Field, Cameron S.
    Hunn, Martin K.
    Ferguson, Peter M.
    Yagita, Hideo
    Hermans, Ian F.
    Ancelet, Lindsay R.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [7] Evaluation of the immune response following treatment with anti-CTLA-4 antibody, radiation therapy or the combination in a murine model of breast cancer
    Franklin, Maryland R.
    Thayer, Matt
    Draper, David
    Saims, Dan
    Wise, Scott
    CANCER RESEARCH, 2016, 76
  • [8] Dissecting the therapeutic effects of anti-CTLA-4 and ADT in a murine hormone-sensitive prostate cancer
    Subudhi, Sumit Kumar
    Montalvo-Ortiz, Welby
    Scher, Howard I.
    Allison, James Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [9] Imaging lymphatic delivery of anti CTLA-4 and its anti-tumor response in a non-immunogenic breast cancer model
    Kwon, Sunkuk
    Velasquez, Fred
    Ross, Russell
    Hwu, Wen
    Sevick, Eva
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [10] Role of anti-CTLA-4 therapies in the treatment of cancer
    Abrams, SI
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (01) : 71 - 77
12345